Joanne Wuensch
Stock Analyst at Citigroup
(4.36)
# 358
Out of 5,109 analysts
441
Total ratings
64.6%
Success rate
11.65%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Neutral | $98 → $94 | $90.07 | +4.36% | 23 | Dec 11, 2025 | |
| SYK Stryker | Maintains: Buy | $455 → $420 | $354.74 | +18.40% | 15 | Dec 11, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $5.5 → $9.1 | $9.00 | +1.11% | 14 | Dec 11, 2025 | |
| JNJ Johnson & Johnson | Maintains: Buy | $215 → $232 | $207.78 | +11.66% | 16 | Dec 11, 2025 | |
| ITGR Integer Holdings | Maintains: Neutral | $69 → $75 | $78.82 | -4.85% | 9 | Dec 11, 2025 | |
| GKOS Glaukos | Maintains: Buy | $113 → $125 | $116.64 | +7.17% | 23 | Dec 11, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $83 → $88 | $83.39 | +5.53% | 8 | Dec 11, 2025 | |
| ESTA Establishment Labs Holdings | Maintains: Neutral | $62 → $75 | $76.25 | -1.64% | 8 | Dec 11, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $96 → $101 | $86.35 | +16.97% | 22 | Dec 11, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $16 → $22 | $22.43 | -1.92% | 21 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $75 → $77 | $67.42 | +14.21% | 17 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $285 → $350 | $316.50 | +10.58% | 26 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $650 → $635 | $577.15 | +10.02% | 18 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $77 → $88 | $80.14 | +9.81% | 10 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $88 | $82.57 | +6.58% | 22 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $12 → $11 | $12.68 | -13.25% | 16 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $26 → $21 | $19.11 | +9.89% | 22 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $205 → $242 | $176.89 | +36.81% | 22 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $112 | $97.27 | +15.14% | 22 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $157 → $155 | $124.81 | +24.19% | 22 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $17.03 | -11.92% | 6 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6.5 → $4.15 | $2.28 | +82.02% | 12 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $380 | $288.95 | +31.51% | 16 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $119 → $125 | $96.13 | +30.03% | 35 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $196.12 | +27.47% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $80.17 | -13.93% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $244.98 | -48.16% | 6 | Dec 10, 2018 |
Zimmer Biomet Holdings
Dec 11, 2025
Maintains: Neutral
Price Target: $98 → $94
Current: $90.07
Upside: +4.36%
Stryker
Dec 11, 2025
Maintains: Buy
Price Target: $455 → $420
Current: $354.74
Upside: +18.40%
Sight Sciences
Dec 11, 2025
Maintains: Neutral
Price Target: $5.5 → $9.1
Current: $9.00
Upside: +1.11%
Johnson & Johnson
Dec 11, 2025
Maintains: Buy
Price Target: $215 → $232
Current: $207.78
Upside: +11.66%
Integer Holdings
Dec 11, 2025
Maintains: Neutral
Price Target: $69 → $75
Current: $78.82
Upside: -4.85%
Glaukos
Dec 11, 2025
Maintains: Buy
Price Target: $113 → $125
Current: $116.64
Upside: +7.17%
GE HealthCare Technologies
Dec 11, 2025
Maintains: Neutral
Price Target: $83 → $88
Current: $83.39
Upside: +5.53%
Establishment Labs Holdings
Dec 11, 2025
Maintains: Neutral
Price Target: $62 → $75
Current: $76.25
Upside: -1.64%
Edwards Lifesciences
Dec 11, 2025
Maintains: Buy
Price Target: $96 → $101
Current: $86.35
Upside: +16.97%
Tandem Diabetes Care
Dec 11, 2025
Maintains: Neutral
Price Target: $16 → $22
Current: $22.43
Upside: -1.92%
Dec 11, 2025
Maintains: Buy
Price Target: $75 → $77
Current: $67.42
Upside: +14.21%
Dec 11, 2025
Upgrades: Buy
Price Target: $285 → $350
Current: $316.50
Upside: +10.58%
Dec 11, 2025
Downgrades: Neutral
Price Target: $650 → $635
Current: $577.15
Upside: +10.02%
Dec 11, 2025
Downgrades: Neutral
Price Target: $77 → $88
Current: $80.14
Upside: +9.81%
Dec 8, 2025
Maintains: Neutral
Price Target: $72 → $88
Current: $82.57
Upside: +6.58%
Oct 31, 2025
Maintains: Sell
Price Target: $12 → $11
Current: $12.68
Upside: -13.25%
Oct 31, 2025
Maintains: Neutral
Price Target: $26 → $21
Current: $19.11
Upside: +9.89%
Oct 31, 2025
Maintains: Buy
Price Target: $205 → $242
Current: $176.89
Upside: +36.81%
Oct 7, 2025
Maintains: Buy
Price Target: $101 → $112
Current: $97.27
Upside: +15.14%
Jul 18, 2025
Maintains: Buy
Price Target: $157 → $155
Current: $124.81
Upside: +24.19%
Jul 9, 2025
Maintains: Neutral
Price Target: $13 → $15
Current: $17.03
Upside: -11.92%
May 22, 2025
Maintains: Neutral
Price Target: $6.5 → $4.15
Current: $2.28
Upside: +82.02%
May 22, 2025
Maintains: Buy
Price Target: $320 → $380
Current: $288.95
Upside: +31.51%
May 22, 2025
Maintains: Buy
Price Target: $119 → $125
Current: $96.13
Upside: +30.03%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $196.12
Upside: +27.47%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $80.17
Upside: -13.93%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $244.98
Upside: -48.16%